The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)

Qiulu Zhong; Danjing Luo; Da Chen; Xiangde Li; Qinghua Du; Qianfu Liang; Jian Li; Xiaodong Zhu

doi:doi:10.18632/aging.204942

← Back

Research Paper Volume 15, Issue 15 pp 7781—7793

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)

Figure 5. Kaplan-Meier curve for time to tumor progression for gliomas with different IDH status. The PFS of patients with IDH mutated/1p/19q codeletion or 1p/19q non codeletion were longer than that of IDH-wild type patients.